Novel Oncometabolites and Metabolic Checkpoints Involved in Hepatocellular Carcinoma Development

Overview

Journal J Hepatol

Publisher Elsevier

Specialty Gastroenterology

Date 2023 Jan 14

PMID 36640958

Authors

Davide Povero

Affiliations

Soon will be listed here.

Citing Articles

Roles of protein post-translational modifications in glucose and lipid metabolism: mechanisms and perspectives.

Yang Y, Wen R, Yang N, Zhang T, Liu C Mol Med. 2023; 29(1):93.

PMID: 37415097 PMC: 10327358. DOI: 10.1186/s10020-023-00684-9.

References

Osthus R, Shim H, Kim S, Li Q, Reddy R, Mukherjee M . Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem. 2000; 275(29):21797-800. DOI: 10.1074/jbc.C000023200. View

Lemons J, Feng X, Bennett B, Legesse-Miller A, Johnson E, Raitman I . Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol. 2010; 8(10):e1000514. PMC: 2958657. DOI: 10.1371/journal.pbio.1000514. View

Liberti M, Locasale J . Correction to: 'The Warburg Effect: How Does it Benefit Cancer Cells?': [Trends in Biochemical Sciences, 41 (2016) 211]. Trends Biochem Sci. 2018; 41(3):287. DOI: 10.1016/j.tibs.2016.01.004. View

Rao A, DeBerardinis R . Metabolic vulnerability in tumours illuminated. Nature. 2019; 575(7782):296-297. DOI: 10.1038/d41586-019-03239-3. View

Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag C, Vignat J . Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022; 77(6):1598-1606. PMC: 9670241. DOI: 10.1016/j.jhep.2022.08.021. View

Ericksen R, Lim S, McDonnell E, Shuen W, Vadiveloo M, White P . Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression. Cell Metab. 2019; 29(5):1151-1165.e6. PMC: 6506390. DOI: 10.1016/j.cmet.2018.12.020. View

Bjornson E, Mukhopadhyay B, Asplund A, Pristovsek N, Cinar R, Romeo S . Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization. Cell Rep. 2015; 13(9):2014-26. DOI: 10.1016/j.celrep.2015.10.045. View

Sun J, Ding J, Shen Q, Wang X, Wang M, Huang Y . Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma. J Hepatol. 2022; 78(3):627-642. DOI: 10.1016/j.jhep.2022.11.017. View

Warburg O . On respiratory impairment in cancer cells. Science. 1956; 124(3215):269-70. View

10.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

11.

DeBerardinis R, Chandel N . Fundamentals of cancer metabolism. Sci Adv. 2016; 2(5):e1600200. PMC: 4928883. DOI: 10.1126/sciadv.1600200. View

12.

Metallo C, Gameiro P, Bell E, Mattaini K, Yang J, Hiller K . Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature. 2011; 481(7381):380-4. PMC: 3710581. DOI: 10.1038/nature10602. View

13.

Pavlova N, Zhu J, Thompson C . The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022; 34(3):355-377. PMC: 8891094. DOI: 10.1016/j.cmet.2022.01.007. View

14.

Peng X, Chen Z, Farshidfar F, Xu X, Lorenzi P, Wang Y . Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Rep. 2018; 23(1):255-269.e4. PMC: 5916795. DOI: 10.1016/j.celrep.2018.03.077. View

15.

Amann T, Maegdefrau U, Hartmann A, Agaimy A, Marienhagen J, Weiss T . GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol. 2009; 174(4):1544-52. PMC: 2671384. DOI: 10.2353/ajpath.2009.080596. View

16.

Shin H, Cha H, Lee M, Na K, Park D, Kim C . Identification of ALDH6A1 as a Potential Molecular Signature in Hepatocellular Carcinoma via Quantitative Profiling of the Mitochondrial Proteome. J Proteome Res. 2020; 19(4):1684-1695. DOI: 10.1021/acs.jproteome.9b00846. View

17.

Povero D, Johnson S, Liu J . Hypoxia, hypoxia-inducible gene 2 (HIG2)/HILPDA, and intracellular lipolysis in cancer. Cancer Lett. 2020; 493:71-79. PMC: 11218043. DOI: 10.1016/j.canlet.2020.06.013. View

18.

Sun H, Yu X, Wu W, Chen J, Shi M, Zheng L . GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma. PLoS One. 2016; 11(12):e0168907. PMC: 5201247. DOI: 10.1371/journal.pone.0168907. View

19.

Zhang X, Saarinen A, Hitosugi T, Wang Z, Wang L, Ho T . Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia. Elife. 2017; 6. PMC: 5739538. DOI: 10.7554/eLife.31132. View

20.

Beyoglu D, Idle J . Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites. 2020; 10(2). PMC: 7074571. DOI: 10.3390/metabo10020050. View